Prometic obtains controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
ProMetic Life Sciences Inc. announced that it has finalized its intended transaction with the American Red Cross (ARC) to acquire, in a non-cash transaction, its common stock holding in Pathogen Removal and Diagnostic Technologies Inc. (PRDT). The transaction, originally announced in Apri ... more
